Costafreda Sergi G, Khanna Akash, Mourao-Miranda Janaina, Fu Cynthia H Y
Institute of Psychiatry, King's College London, De Crespigny Park, London, UK.
Neuroreport. 2009 May 6;20(7):637-41. doi: 10.1097/WNR.0b013e3283294159.
Currently, there are no neurobiological markers of clinical response for cognitive behavioural therapy (CBT) used in clinical practice. We investigated the neural pattern of activity to implicit processing of sad facial expressions as a predictive marker of clinical response. Sixteen medication-free patients in an acute episode of major depression underwent functional magnetic resonance imaging scans before treatment with CBT. Nine patients showed a full clinical response. The pattern of activity, which predicted clinical response, was analysed with support vector machine and leave-one-out cross-validation. The functional neuroanatomy of sad faces at the lowest and highest intensities identified patients, before the initiation of therapy, who had a full clinical response to CBT (sensitivity 71%, specificity 86%, P = 0.029).
目前,临床实践中使用的认知行为疗法(CBT)尚无临床反应的神经生物学标志物。我们研究了对悲伤面部表情进行隐式加工时的神经活动模式,将其作为临床反应的预测标志物。16名处于重度抑郁症急性发作期且未服用药物的患者在接受CBT治疗前进行了功能磁共振成像扫描。9名患者显示出完全的临床反应。使用支持向量机和留一法交叉验证分析了预测临床反应的活动模式。在治疗开始前,通过最低和最高强度悲伤面孔的功能神经解剖学识别出了对CBT有完全临床反应的患者(敏感性71%,特异性86%,P = 0.029)。